Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 17, 2021
Cardiovascular risk management in type 2 diabetes mellitus: A joint position paper of the Italian Cardiology (SIC) and Italian Diabetes (SID) SocietiesAngelo Avogaro, Francesco Barillà, Franco Cavalot, et al.
Diabetes Technology & Therapeutics|October 28, 2014
A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetesF Javier Ampudia-Blasco, Pierre Yves Benhamou, Guillaume Charpentier, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|August 15, 2022
Health care organization and use of technological devices in people with diabetes in Italy: Results from a survey of the Working Group on Diabetes and TechnologyDario Pitocco, Andrea Laurenzi, Letizia Tomaselli, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 15, 2009
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cellsSimonetta Bacci, Rosa Di Paola, Claudia Menzaghi, et al.
Diabetes Care|September 16, 2017
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 DiabetesFrancesca Santilli, Paola G Simeone, Maria T Guagnano, et al.
The New England Journal of Medicine|September 17, 2016
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesSteven P Marso, Stephen C Bain, Agostino Consoli, et al.
Diabetes/Metabolism Research and Reviews|November 1, 2019
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose toleranceFrancesca Santilli, Francesco Zaccardi, Rossella Liani, et al.
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|August 1, 2020
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular PreventionMassimo Volpe, Allegra Battistoni, , et al.
Diabetes, Obesity & Metabolism|June 2, 2020
Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panelAgostino Consoli, Leszek Czupryniak, Rui Duarte, et al.
Pageof 10